FDA WARNING_LETTER - Manabi Export Panama S.A. - April 25, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On August 14, 2024, the FDA issued a Warning Letter to Manabi Export Panama S.A. following an inspection of their seafood processing facility in Chepo, Panama, on April 24-25, 2024. The inspection revealed serious violations of the seafood HACCP regulation (21 CFR 123), rendering their ready-to-eat (RTE) cooked clam meat in reduced oxygen packaging (ROP) adulterated under 21 U.S.C. § 342(a)(4).
The firm failed to conduct a hazard analysis and implement a written HACCP plan for their RTE clam meat, specifically lacking controls for: natural toxins and environmental chemicals at receiving, pathogenic bacteria survival through cooking, *Clostridium botulinum* toxin formation at labeling, and pathogen growth/toxin formation during post-cooking steps. Additionally, the firm lacked written sanitation procedures and adequate sanitation control records for various critical areas, including food contact surfaces, cross-contamination, handwashing facilities, and pest control, violating 21 CFR 123.11(c).
The FDA acknowledged the firm's May 8, 2024, response, which included a HACCP course receipt, but deemed it inadequate. Manabi Export Panama S.A. must respond within fifteen working days, outlining specific corrective actions, including a copy of their Hazard Analysis and HACCP plan,
ID · e6355ea1-96cb-4f9a-b489-5170333082ca
Full citation text and observation details available on the Dashboard.